Euro Asian Pharma represents many internationally reputed pharmaceutical companies in the Sri Lankan market. Our main principals include:

Orchid Chemicals & Pharmaceuticals Ltd

Orchid Chemicals & Pharmaceuticals Ltd (Orchid) was established in 1992 as a 100% Export Oriented Unit (EOU). Commencing operations in 1994, Orchid has achieved rapid growth to emerge among the Top-15 companies in the Indian pharmaceutical industry in a short span of twelve years of operations. Orchid employs over 3200 people, of which over 600 are scientists, technologists and other professionals. 

Orchid is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well as in drug discovery. From the very inception, Orchid has been investing aggressively for establishing modern research and manufacturing facilities aimed at global markets, thus emerging as a world-class pharmaceutical company covering the entire value chain from “Discovery to Delivery”.

Euro Asian Pharma has represented Orchid in Sri Lanka for the local marketing since 2002 (former Mano Pharma).

Excerpt from

Piramal Healthcare Ltd

Piramal Healthcare is the flagship company of the Piramal Group and is a world leader in its various business verticals. It has a global footprint of over 100 countries, manufacturing bases in USA, Great Britain, Sri Lanka, China and Canada and a diversified workforce representing the Piramal Group’s diversified global portfolio.

Piramal Critical Care is a business unit of Piramal Healthcare Limited. Its Worldwide Product Portfolio includes an extensive range of Inhalation Anesthetics like Sevoflurane, Halothane, Isoflurane and Enflurane, Intravenous Anesthetics like Propofol, Regional Anesthetics like Bupivacaine, Muscle Relaxants like Atracurium and Plasma Volume Expanders like Polygeline.*

Pirmal critical care is committed to providing high quality products and services to fulfill the unmet medical needs in critical care.

Euro Asian Pharma has represented Piramal Healthcare Ltd (Formerly known as Nicholas Piramal India Ltd in Sri Lanka for the local marketing since 2003.

Excerpt from &

Atoz Pharmaceuticals (Pvt) Ltd

ATOZ is an enterprising company located in Chennai, India, with an area of 2 acres and built up area of 45000 Square feet as per WHO GMP standards. Atoz has steadily built up an impressive list of clientele spread all over India and exports many of its formulations to various countries.

ATOZ is in niche areas like soft gel formulations and also in providing its other formulations like Tablets and Capsules in state of art packing ALU-ALU/TROPICAL BLISTER.

Euro Asian Pharma has represented Atoz Pharmaceuticals in Sri Lanka for the local marketing since 2004.

Excerpt from

Pregna International Ltd

Pregna International Ltd. is a leading manufacturer of Intra-Uterine Contraceptive Devices, Tubal Rings and Laparoscopes. Established in the year 1996, Pregna has been in the forefront for providing contraceptive solutions.

Euro Asian Pharma has represented Pregna in Sri Lanka for the local marketing since 2004.

Excerpt from

Crescent Therapeutics Ltd

Crescent Therapeutics Limited is the manufacturing arm of the Crescent Group, a young, vibrant organization that is committed to deliver quality healthcare and customer service beyond compare.

Crescent Therapeutics has a state-of-the-art manufacturing facility at Baddi, Himachal Pradesh, India. The facility, which is approved by WHO-GMP, is capable of manufacturing various oral solid dosage forms including tablets, capsules with different release patterns, D C granules, pellets, powders and nutraceuticals. The manufacturing facility complies with the regulatory requirements of various international regulatory authorities like UK MHRA, TGA of Australia, MCC of South Africa, ANVISA of Brazil etc., With a client base of over thirty leading domestic pharmaceutical companies, the company is aggressively pursuing the rapidly growing contract manufacturing and formulation development space.

Excerpt from